These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32790899)

  • 1. Novel insights into the function of CD24: A driving force in cancer.
    Altevogt P; Sammar M; Hüser L; Kristiansen G
    Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
    Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
    Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
    Chen C; Zhang L; Ruan Z
    Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
    Li X; Tian W; Jiang Z; Song Y; Leng X; Yu J
    Cancer Immunol Immunother; 2024 Jan; 73(2):31. PubMed ID: 38279998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
    Shen W; Shi P; Dong Q; Zhou X; Chen C; Sui X; Tian W; Zhu X; Wang X; Jin S; Wu Y; Chen G; Qiu L; Zhai W; Gao Y
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling CD24-Siglec-10 pathway: Cancer immunotherapy from basic science to clinical studies.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Immunology; 2024 Nov; 173(3):442-469. PubMed ID: 39129256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
    Lin CY; Tsai CL; Chao A; Lee LY; Chen WC; Tang YH; Chao AS; Lai CH
    J Mol Med (Berl); 2021 Aug; 99(8):1125-1137. PubMed ID: 33954835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.
    Shapira S; Kazanov D; Weisblatt S; Starr A; Arber N; Kraus S
    J Biol Chem; 2011 Nov; 286(47):40548-55. PubMed ID: 21976680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.
    Chen GY; Tang J; Zheng P; Liu Y
    Science; 2009 Mar; 323(5922):1722-5. PubMed ID: 19264983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.
    Sammar M; Siwetz M; Meiri H; Fleming V; Altevogt P; Huppertz B
    Histochem Cell Biol; 2017 May; 147(5):565-574. PubMed ID: 28012129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint CD24 function on tumor and immunotherapy.
    Huang S; Zhang X; Wei Y; Xiao Y
    Front Immunol; 2024; 15():1367959. PubMed ID: 38487533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis.
    Kristiansen G; Machado E; Bretz N; Rupp C; Winzer KJ; König AK; Moldenhauer G; Marmé F; Costa J; Altevogt P
    Lab Invest; 2010 Jul; 90(7):1102-16. PubMed ID: 20351695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological roles of CD24 in ovarian cancer: old story, but new tales.
    Gu Y; Zhou G; Tang X; Shen F; Ding J; Hua K
    Front Immunol; 2023; 14():1183285. PubMed ID: 37359556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.
    Wang X; Liu M; Zhang J; Brown NK; Zhang P; Zhang Y; Liu H; Du X; Wu W; Devenport M; Tao W; Mao-Draayer Y; Chen GY; Chen YE; Zheng P; Liu Y
    Cell Metab; 2022 Aug; 34(8):1088-1103.e6. PubMed ID: 35921817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of CD24 as a new molecular marker in ovarian cancer.
    Tarhriz V; Bandehpour M; Dastmalchi S; Ouladsahebmadarek E; Zarredar H; Eyvazi S
    J Cell Physiol; 2019 Mar; 234(3):2134-2142. PubMed ID: 30317611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10.
    Yin SS; Gao FH
    Front Immunol; 2020; 11():1324. PubMed ID: 32765491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1-Mediated Expression of CD24 and Epigenetic Suppression of Novel Tumor Suppressor miR-1185-1 Increases Colorectal Cancer Stemness.
    Wang TW; Chern E; Hsu CW; Tseng KC; Chao HM
    Cancer Res; 2020 Dec; 80(23):5257-5269. PubMed ID: 33046442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.
    Smith SC; Oxford G; Wu Z; Nitz MD; Conaway M; Frierson HF; Hampton G; Theodorescu D
    Cancer Res; 2006 Feb; 66(4):1917-22. PubMed ID: 16488989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer.
    Mishra AK; Ye T; Banday S; Thakare RP; Su CT; Pham NNH; Ali A; Kulshreshtha A; Chowdhury SR; Simone TM; Hu K; Zhu LJ; Eisenhaber B; Deibler SK; Simin K; Thompson PR; Kelliher MA; Eisenhaber F; Malonia SK; Green MR
    Cell Rep; 2024 Apr; 43(4):114041. PubMed ID: 38573857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
    Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
    Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.